3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Carcinoma
6
Lung Neoplasms
5
Nasopharyngeal Carcinoma
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Medulloblastoma
1
Locally Advanced Cervical Adenocarcinoma
1
Liver Neoplasms
1
Interventions
pembrolizumab
2
Paclitaxel
2
Carboplatin
2
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vaginal Smears
1
Trastuzumab
1
Sutures
1
Sunitinib
1
Specimen Handling
1
Radionuclide Imaging
1
Papanicolaou Test
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
30 days
×
Clear all
No trials found.